Sophia Genetics SA :A loss of 39 cents per share anticipated for second quarter

Sophia Genetics SA

08/09/2021 14:51

8 September 202101:51 p.m. All figures in US dollars. 
Sophia Genetics SA is expected to report second quarter earnings
of  -39 cents​ per share according to the mean Refinitiv
estimate from two analysts. Wall Street expects results to range
from a loss of -40 cents to ​a loss of -38 cents per share.  
 
RECOMMENDATIONS 
* The consensus recommendation for the company is "Buy". This
includes four "Buy". 
* The average consensus recommendation for the advanced medical
equipment & technology peer group is also "Buy". 
 
FORECAST CHANGES
* Two analysts are currently providing Refinitiv with
estimates. 
* In the last week there have been no earnings estimate
revisions by analysts covering the company. There were no
changes to the number of estimates.
* A consensus earnings per share estimate is not available for
the last four weeks.     .  There has been no changes to the
number of estimates.
* The StarMine predicted earnings surprise is too low to be
considered statistically significant. Predicted revenue surprise
is too low to be significant.
* The average price target from the two analysts providing
estimates is $23.
 
YEAR OVER YEAR
* The company is expected to report revenue of $8.6 million, a
figure is not available for the same quarter last year.
* No EPS actual value is available for the same quarter last
year.     
* Previous quarterly performance (using preferred earnings
measure)
 QUARTER ENDING    ESTIMATE       ACTUAL         BEAT, MET,
                                                 MISSED
 Jun. 30 2021      0.26           0.29           Beat
 Mar. 31 2021      0.27           0.29           Beat
 Dec. 31  2020     0.31           0.35           Beat
 Sep. 30 2020      0.32           0.41           Beat
 
This summary was machine generated from Refinitiv data September
8 at 01:51 p.m